The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels

Experimental Cell Research

Volumn 312, Issue 18, 2006, Pages 3693-3700

  King, Taj D ^a   Gandy, Johanna C ^a   Bijur, Gautam N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Akt; Glycogen synthase kinase 3; Inhibitor 2; Protein phosphatase 1; Sarcoplasmic Endoplasmic reticulum calcium ATPase

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ADENOSINE TRIPHOSPHATASE (CALCIUM); GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LITHIUM; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; POTASSIUM CHLORIDE;

ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SARCOPLASMIC RETICULUM; STATISTICAL SIGNIFICANCE;

EID: 33749119114     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.08.010     Document Type: Article

References (42)

1. Andjelkovic M., Jakubowicz T., Cron P., Ming X.F., Han J.W., and Hemmings B.A. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5699-5704
2. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
3. 2+ pump. J. Biol. Chem. 264 (1989) 18561-18568
4. Carmel G., Mager E.M., Binder L.I., and Kuret J. The structural basis of monoclonal antibody Alz59's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271 (1996) 32789-32795
5. Ceulemans H., and Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84 (2004) 1-39
6. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
7. Cross D.A., Culbert A.A., Chalmers K.A., Facci L., Skaper S.D., and Reith A.D. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death. J. Neurochem. 77 (2001) 94-102
8. Crowder R.J., and Freeman R.S. The survival of sympathetic neurons promoted by potassium depolarization, but not by cyclic AMP, requires phosphatidylinositol 3-kinase and Akt. J. Neurochem. 73 (1999) 466-475
9. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 12 (1999) 3499-3511
10. DePaoli-Roach A.A. Synergistic phosphorylation and activation of ATP-Mg-dependent phosphoprotein phosphatase by F A/GSK-3 and casein kinase II. J. Biol. Chem. 259 (1984) 12144-12152
11. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., and Gogos J.A. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia. Nat. Genet. 36 (2004) 131-137
12. Embi N., Rylatt D.B., and Cohen P. Glycogen synthase kinase-3: an emerging therapeutic target. Trends Mol. Med. 8 (1980) 0664-9660
13. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase-3β in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
15. Hartigan J.A., and Johnson G.V. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J. Biol. Chem. 274 (1999) 21395-21401
16. Hardt S.E., and Sadoshima J. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90 (2002) 1055-1063
17. Hill M.M., and Hemmings B.A. Inhibition of protein kinase B/Akt. Implications for cancer therapy. Pharmacol. Ther. 93 (2002) 243-251
18. Holmes C.F., Kuret J., Chisholm A.A., and Cohen P. Identification of the sites on rabbit skeletal muscle protein phosphatase inhibitor-2 phosphorylated by casein kinase-II. Biochim. Biophys. Acta 870 (1986) 408-416
19. Huang F.L., and Glinsmann W.H. Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur. J. Biochem. 70 (1976) 419-426
20. Johnson G.V., Seubert P., Cox T.M., Motter R., Brown J.P., and Galasko D. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68 (1997) 430-433
21. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
22. Kaidanovich O., and Eldar-Finkelman H. The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin. Ther. Targets 6 (2002) 555-561
23. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8455-8459
24. Lee Y.I., Seo M., Kim Y., Kim S.Y., Kang U.G., Kim Y.S., and Juhnn Y.S. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase-3β, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 280 (2005) 22044-22052
25. Mandelkow E.M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J.R., and Mandelkow E. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314 (1992) 315-321
26. Manoukian A.S., and Woodgett J.R. Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv. Cancer Res. 84 (2002) 203-229
27. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., and Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23 (2000) 222-229
28. Meier R., Thelen M., and Hemmings B.A. Inactivation and dephosphorylation of protein kinase Bα (PKBα) promoted by hyperosmotic stress. EMBO J. 24 (1998) 7294-7303
29. Michael A., Haq S., Chen X., Hsich E., Cui L., Walters B., Shao Z., Bhattacharya K., Kilter H., Huggins G., Andreucci M., Periasamy M., Solomon R.N., Liao R., Patten R., Molkentin J.D., and Force T. Glycogen synthase kinase-3β regulates growth, calcium homeostasis, and diastolic function in the heart. J. Biol. Chem. 279 (2004) 21383-21393
30. Miller T.M., Tansey M.G., Johnson Jr. E.M., and Creedon D.J. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells. J. Biol. Chem. 272 (1997) 9847-9853
31. Morfini G., Szebenyi G., Brown H., Pant H.C., Pigino G., DeBoer S., Beffert U., and Brady S.T. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23 (2004) 2235-2245
32. Oliver C.J., and Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front. Biosci. 3 (1998) 961-972
33. Otvos Jr. L., Feiner L., Lang E., Szendrei G.I., Goedert M., and Lee V.M. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39 (1994) 669-673
34. Song L., De Sarno P., and Jope R.S. Central role of glycogen synthase kinase-3β in endoplasmic reticulum stress-induced caspase-3 activation. J. Biol. Chem. 277 (2002) 44701-44708
35. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6 (1996) 1664-1668
36. Sutherland C., Leighton I.A., and Cohen P. Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signaling. Biochem. J. 296 (1993) 15-19
37. Szatmari E., Habas A., Yang P., Zheng J., Hagg T., and Hetman M. A positive feedback loop between glycogen synthase kinase-3β and protein phosphatase-1 after stimulation of NR2B NMDA receptors in forebrain neurons. J. Biol. Chem. 280 (2005) 37526-37535
38. 2+-ATPase. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 2466-2470
39. Welsh G.I., and Proud C.G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 294 (1993) 625-629
40. Woodgett Jr. J.R., and Cohen P. Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochem. Biophys. Acta 14 (1984) 339-347
41. 2+-ATPase isoform transcripts. Am. J. Physiol. 269 (1995) 775-784
42. Zhang F., Phiel C.J., Spece L., Gurvich N., and Klein P.S. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J. Biol. Chem. 278 (2003) 33067-33077